In June 2017, the Health Information and Quality Authority (HIQA) commenced work on a health technology assessment (HTA) in relation to proposed changes to the national human papillomavirus (HPV) immunisation programme. HIQA agreed to undertake the HTA following a formal request from the Department of Health for a HTA.
Draft HTA of extending the national immunisation schedule to include HPV vaccination of boys
What the public consultation is about?
This HTA is being carried out to assess the impact of changing from a policy of a girls-only school-based HPV immunisation programme to a policy of offering the HPV vaccine to both girls and boys (gender-neutral immunisation). The effect of different HPV vaccine uptake rates among girls on the clinical and cost-effectiveness of extending the immunisation schedule to include boys will also be assessed.
Based on this HTA, the Minister for Health will decide whether there should be a change in the national immunisation programme to extend the current programme, which offers HPV vaccination to all girls in their first year of second-level education (12 to 13 year olds), to a programme that also offers vaccination to boys. In consultation with the Department of Health, HIQA’s Evaluation Team developed questions in relation to the critical information required to inform such a decision.
How to give feedback
We welcome your views to help inform the final reccomendations to the Minister.
- Complete online survey here.
- Or complete a PDF version of the consultation form available below, and e-mail the completed consultation form to email@example.com or post the consultation form to:
Health Information and Quality Authority
HTA on extending the immunisation schedule to include HPV vaccination of boys